Patients' adherence to osteoporosis therapy: Exploring the perceptions of postmenopausal women

Canadian Family Physician

Volumn 54, Issue 3, 2008, Pages 394-402

  Lau, Elaine ^c   Papaioannou, Alexandra ^a   Dolovich, Lisa ^a   Adachi, Jonathan ^b   Sawka, Anna M ^b   Burns, Sheri ^b   Nair, Kalpana ^b   Pathak, Anjali ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b St Joseph's Healthcare ^*

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY CARE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; MALE; PATIENT MONITORING; PHENOLOGY; POSTMENOPAUSE OSTEOPOROSIS; SEMI STRUCTURED INTERVIEW;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BONE DENSITY CONSERVATION AGENTS; COMMUNICATION; DECISION MAKING; FEMALE; FOCUS GROUPS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS;

EID: 40949144450     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lorrain J, Paiemont G, Chevalier N, Lalumiere G, Laflamme GH, Caron P, et al. Population demographics and socioeconomic impact of osteoporosis in Canada. Menopause 2003;10:228-34.
2. Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:16-23.
3. Goeree R, O'Brien B, Pettitt D, Cuddy L, Ferraz M, Adachi J. An assessment of the burden of illness due to osteoporosis in Canada. J Soc Obstet Gynaecol Can 1996;18(July Suppl):15-24.
4. Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, et al. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int 2004;74:129-35.
5. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006;38:922-8.
6. Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and non-vertebral fractures from 2 US claims databases. Mayo Clin Proc 2006;81:1013-22.
7. Caroj J, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004;15:1003-8.
8. Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, et al. Early discontinuation of treatment for osteoporosis. Am J Med 2003;115:209-16.
9. McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004;48:271-87.
10. Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005;21:1453-60.
11. Yood RA, Emani S, Reed JI, Lewis BE, Charpentier M, Lydick E. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 2003;14:965-8.
12. Papaioannou A, Ioannidis G, Adachi JD, Sebaldt R, Ferko N, Puglia M, et al. Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 2003;14:808-13.
13. Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 2006;17:1645-52.
14. Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 2005;80:856-61.
15. Hamilton B, McCoy K, Taggart H. Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 2003;14:259-62.
16. Carr AJ, Thompson PW, Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int 2006;17:1638-44.
17. Penning-van Beest FJ, Goettsch WG, Erkens JA, Herings RM. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Clin Ther 2006;28:236-42.
18. Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, et al. Compliance with osteoporosis medications. Arch Intern Med 2005;165:2414-9.
19. Unson CG, Siccion E, Gaztambide J, Gaztambide S, Mahoney Trella P, Prestwood K. Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Womens Health 2003;12:1037-45.
20. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2005;(4):CD000011. DOI: 10.1002/14651858.CD000011.pub2.
21. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005;39:319-28.
22. Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 2004;89:1117-23.
23. Tattersall RL. The expert patient: a new approach to chronic disease management for the twenty-first century. Clin Med 2002;2:227-9.
24. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med 1997;127:1097-102.
25. Lincoln YS, Guba EG, editors. Naturalistic inquiry. Newbury Park, CA: Sage Publications; 1985.
26. Patton MQ, editor. Qualitative evaluation and research methods. 2nd ed. Newbury Park, CA: Sage Publications; 1990.
27. Kitzinger J. Introducing focus groups. BMJ 1995;311:299-302.
28. Ashbury J. Overview of focus group research. Qual Health Res 1999;5:414-20.
29. Creswell JW, editor. Qualitative inquiry and research design: choosing among five traditions. Thousand Oaks, CA: Sage Publications; 1998.
30. Qualitative Solutions and Research Pty Ltd. QSR NUD*IST Vivo (NVivo). Thousand Oaks, CA: Scolari Software Inc, Sage Publications; 1999.
31. Kolbe J, Vamos M, James F, Elkind G, Garrett J. Assessment of practical knowledge of self-management of acute asthma. Chest 1996;109:86-90.
32. Boulet L-P, Boutin H, Cote J, Leblanc P, Laviolette M. Evaluation of an asthma self-management education program. J Asthma 1995;32:199-206.
33. Cole RP, Palushock S, Haboubi A. Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing. Women Health 1999;29:101-15.
34. Johnson MJ. The Medication Adherence Model: a guide for assessing medication taking. Res Theory Nurs Pract 2002;16:179-92.
35. Woods NF, Falk S, Saver B, Taylor TR, Stevens N, MacLaren A. Deciding about hormone therapy: validation of a model. Menopause 1998;5:52-9.
36. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS 2000;14:155-68.
37. Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with "non-adherent" patients: a qualitative study. Br J Gen Pract 2002;52:24-32.
38. Johnson MJ, Williams M, Marshall ES. Adherent and nonadherent medication-taking in elderly hypertensive patients. Clin Nurs Res 1999;8:318-35.